Huntington’s disease (HD) is a progressive brain disorder that is inherited and causes nerve cells in the brain, known as neurons, to break down over time. This degeneration has a wide-ranging impact on an individual’s functional abilities, typically affecting movement, cognitive skills (thinking, reasoning, and memory), and mental health. While Huntington’s disease is considered a rare condition, understanding its complexities is crucial for those affected and their families.
Huntington’s disease is characterized by its genetic nature, often passed down from a parent carrying the mutated gene. Although symptoms can manifest at any age, they most commonly emerge in individuals in their 30s and 40s. When the onset occurs before the age of 20, it is classified as juvenile Huntington’s disease. Early-onset Huntington’s can present with different symptoms and may progress more rapidly than adult-onset HD.
While there is currently no cure for Huntington’s disease and treatments cannot halt or reverse its progression, various therapies and medications are available to help manage the diverse symptoms. These interventions aim to improve the quality of life for individuals living with Huntington’s disease by addressing movement difficulties, cognitive decline, and mental health challenges.
Symptoms of Huntington’s Disease
Huntington’s disease manifests a broad spectrum of symptoms that vary considerably from person to person. The initial symptoms, their severity, and their impact on daily life can differ significantly. Furthermore, the prominence and intensity of specific symptoms can fluctuate throughout the course of the disease. Generally, Huntington’s disease symptoms are categorized into three main areas: movement disorders, cognitive conditions, and mental health conditions.
Movement Disorders
Movement disorders are a hallmark feature of Huntington’s disease. The involuntary movements associated with HD are known as chorea. Chorea can affect muscles throughout the body, particularly in the limbs, face, and tongue. These involuntary movements are often described as jerky, random, and uncontrollable. Beyond chorea, Huntington’s disease can also impair voluntary movements, leading to a range of motor difficulties. Movement-related symptoms may include:
- Chorea (Involuntary jerking or writhing movements): These uncontrolled movements are often the most recognizable motor symptom of Huntington’s disease. They can range in severity from subtle fidgeting to more pronounced and disruptive movements.
- Muscle Rigidity or Contracture (Dystonia): In some individuals, Huntington’s disease can cause muscles to become stiff and rigid (rigidity) or to contract and get stuck in certain positions (dystonia). This can affect posture, balance, and movement fluidity.
- Bradykinesia (Slowed Voluntary Movements): While involuntary movements are prominent, Huntington’s disease also impairs the ability to initiate and execute voluntary movements. This slowness of movement, known as bradykinesia, can make everyday tasks challenging.
- Impaired Gait, Posture, and Balance: The combination of chorea, rigidity, and bradykinesia can significantly affect gait, posture, and balance. Individuals with Huntington’s disease may develop an unsteady walk, have difficulty maintaining an upright posture, and experience increased risk of falls.
- Dysarthria and Dysphagia (Speech and Swallowing Difficulties): The muscles controlling speech and swallowing can also be affected by Huntington’s disease. This can lead to slurred speech (dysarthria) and difficulty swallowing (dysphagia), increasing the risk of choking and aspiration.
- Oculomotor Dysfunction (Slow or Unusual Eye Movements): Huntington’s disease can impact eye movements, causing them to be slow, erratic, or difficult to control. This can affect reading, coordination, and visual perception.
Image: Illustration depicting the autosomal dominant inheritance pattern of Huntington’s disease.
The difficulties with voluntary movements often have a more significant impact on a person’s functional abilities than chorea. These motor impairments can affect the capacity to work, perform daily activities, communicate effectively, and maintain independence.
Cognitive Conditions
Cognitive decline is another core feature of Huntington’s disease. These cognitive symptoms affect various aspects of thinking, reasoning, and mental processing. Cognitive challenges in Huntington’s disease may include:
- Executive Dysfunction (Difficulties with Planning, Organizing, and Prioritizing): Huntington’s disease can impair executive functions, which are higher-level cognitive skills needed for planning, organizing, prioritizing tasks, and making decisions. This can make it hard to manage complex tasks, follow instructions, and maintain focus.
- Perseveration and Inflexibility: Individuals with Huntington’s disease may exhibit perseveration, getting stuck on a particular thought, behavior, or action and struggling to switch to something else. Cognitive inflexibility, or difficulty adapting to new situations or changing plans, is also common.
- Impulsivity and Poor Judgment: Lack of impulse control and impaired judgment can occur in Huntington’s disease, leading to impulsive behaviors, acting without thinking, and socially inappropriate actions.
- Lack of Awareness (Anosognosia): Some individuals with Huntington’s disease may have a reduced awareness of their own symptoms and the impact of the disease on their abilities. This lack of insight, known as anosognosia, can complicate care and management.
- Slowed Processing Speed and Word-Finding Difficulties: Cognitive processing speed can slow down in Huntington’s disease, making it harder to process information quickly and respond promptly. Word-finding difficulties, or trouble retrieving the right words when speaking, are also common.
- Learning and Memory Deficits: Learning new information and retaining memories can become increasingly challenging as Huntington’s disease progresses. This can impact daily learning, recall of recent events, and the ability to adapt to new routines.
Mental Health Conditions
Mental health conditions are frequently associated with Huntington’s disease and are not simply a reaction to the diagnosis. Changes in brain chemistry and function due to HD directly contribute to the development of psychiatric symptoms. Depression is the most common mental health condition in Huntington’s disease. Mental health symptoms may include:
- Depression, Irritability, and Apathy: Depression in Huntington’s disease is a significant clinical feature and is not just reactive depression. Symptoms can include persistent sadness, loss of interest in activities (anhedonia), irritability, and apathy (lack of motivation or emotion).
- Social Withdrawal: Individuals with Huntington’s disease may withdraw from social interactions and activities due to depression, apathy, or cognitive and motor difficulties.
- Sleep Disturbances: Sleep problems, such as insomnia or changes in sleep patterns, are common in Huntington’s disease and can exacerbate other symptoms.
- Fatigue and Loss of Energy: Persistent fatigue and a lack of energy are frequently reported in Huntington’s disease and can significantly impact daily functioning.
- Suicidal Thoughts: Thoughts of death, dying, or suicide are serious concerns in Huntington’s disease. The risk of suicide is elevated, particularly before diagnosis and during periods of declining independence.
Other mental health conditions that can occur in Huntington’s disease include:
- Obsessive-Compulsive Disorder (OCD): Characterized by intrusive, repetitive thoughts (obsessions) and repetitive behaviors (compulsions).
- Mania: A state of abnormally elevated mood, increased energy, impulsivity, and inflated self-esteem.
- Bipolar Disorder: A condition characterized by mood swings between periods of depression and mania.
Weight loss is also a common symptom in Huntington’s disease, particularly as the disease progresses, often due to a combination of factors including increased metabolism, swallowing difficulties, and reduced appetite.
Symptoms of Juvenile Huntington’s Disease
Juvenile Huntington’s disease, which begins before age 20, can present with some variations in symptoms compared to adult-onset HD. Early symptoms in juvenile Huntington’s disease may include:
Behavioral Changes
- Attention Deficit: Difficulty concentrating and maintaining attention.
- Academic Decline: A noticeable drop in school performance.
- Behavioral Problems: Increased irritability, aggression, disruptive behavior, or temper tantrums.
Physical Changes
- Rigidity and Contractures: Muscle stiffness and rigidity are often more prominent in juvenile HD than chorea, particularly in young children, leading to difficulties with walking and movement.
- Tremors: Slight, involuntary shaking movements (tremors) can occur, which is less typical in adult-onset HD where chorea is more dominant.
- Clumsiness and Falls: Increased clumsiness, poor coordination, and frequent falls.
- Seizures: Seizures are more common in juvenile Huntington’s disease than in adult-onset HD.
When to Seek Medical Advice
It is essential to consult a healthcare professional if you observe any changes in movement, emotional state, or cognitive abilities. Symptoms resembling Huntington’s disease can also be associated with other medical conditions, making accurate and timely diagnosis crucial. Early diagnosis allows for appropriate management strategies and support to be implemented.
Causes of Huntington’s Disease
Huntington’s disease is a genetic disorder caused by a mutation in the HTT gene, which provides instructions for making a protein called huntingtin. This gene mutation involves an expanded repeat section of DNA. Specifically, it’s an autosomal dominant inherited condition.
Autosomal Dominant Inheritance
Huntington’s disease follows an autosomal dominant inheritance pattern. This means that only one copy of the mutated gene is sufficient to cause the disease. Genes are inherited in pairs, with one copy from each parent. “Autosomal” signifies that the gene is located on one of the autosomes (non-sex chromosomes).
If one parent carries the Huntington’s disease gene mutation, each child has a 50% chance of inheriting the mutated gene and developing Huntington’s disease. There is also a 50% chance that the child will inherit the normal copy of the gene and not develop HD. The inheritance is random, meaning each pregnancy is an independent event, and the risk remains 50% for each child, regardless of whether previous siblings have inherited the gene.
Risk Factors for Huntington’s Disease
The primary risk factor for Huntington’s disease is having a parent with the condition. If a parent has Huntington’s disease, their children have a 50% risk of inheriting the gene mutation. There are no other established lifestyle or environmental risk factors for developing Huntington’s disease. It is solely determined by genetics.
Complications of Huntington’s Disease
Huntington’s disease is a progressive condition, meaning that functional abilities gradually decline over time. The rate of progression and the lifespan after symptom onset vary among individuals. Typically, the time from the emergence of first symptoms to death ranges from 10 to 30 years. Juvenile Huntington’s disease often has a faster progression, with death usually occurring within 10 to 15 years after symptoms begin.
Depression associated with Huntington’s disease significantly increases the risk of suicide. Research suggests that the suicide risk is particularly elevated before a formal diagnosis and during periods of declining independence and functional capacity.
As Huntington’s disease advances, individuals progressively require more assistance with all aspects of daily living and personal care. In the later stages, many individuals become bedridden and lose the ability to speak. While verbal communication may be lost, individuals with Huntington’s disease generally retain the ability to understand language and maintain awareness of family and friends, although in very late stages, recognition of even close family members may be impaired.
Common causes of death in Huntington’s disease include:
- Pneumonia and Infections: Impaired swallowing and weakened respiratory muscles increase the risk of aspiration pneumonia and other infections.
- Injuries from Falls: Balance and coordination problems increase the risk of falls and subsequent injuries.
- Swallowing Complications: Severe dysphagia can lead to malnutrition, dehydration, and aspiration pneumonia.
Prevention of Huntington’s Disease
There is no way to prevent inheriting the genetic mutation that causes Huntington’s disease. However, for individuals with a family history of HD, several options exist for family planning and genetic counseling.
Genetic testing is available for individuals who have a family history of Huntington’s disease and want to know their risk of developing the condition. Predictive genetic testing can be performed to determine if an individual has inherited the gene mutation. Prenatal testing is also available for couples who are pregnant or planning a pregnancy to determine if the fetus has inherited the gene.
Genetic counseling is highly recommended for individuals and families affected by Huntington’s disease. A genetic counselor can provide information about inheritance patterns, genetic testing options, the implications of test results, and family planning strategies. Counseling can help individuals make informed decisions about testing, reproduction, and managing the psychosocial impact of Huntington’s disease.
For couples at risk of passing on Huntington’s disease, reproductive options include:
- Prenatal Genetic Testing: Testing during pregnancy to determine if the fetus has inherited the HD gene.
- In Vitro Fertilization (IVF) with Donor Sperm or Egg: Using donor sperm or eggs to conceive, eliminating the risk of passing on the HD gene from one parent.
- Preimplantation Genetic Diagnosis (PGD): Combined with IVF, PGD allows embryos to be tested for the Huntington’s disease gene mutation before implantation. Only embryos without the mutation are implanted in the uterus.
Image: Diagram illustrating the process of in vitro fertilization (IVF), a reproductive technology option for families with Huntington’s disease.
These reproductive technologies and genetic counseling provide options for at-risk individuals to make informed choices aligned with their personal and family planning goals.
References:
- AskMayoExpert. Huntington Disease (HD) (adult). Mayo Clinic; 2023.
- Huntington’s disease. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Hope-Through-Research/Huntingtons-Disease-Hope-Through. Accessed March 1, 2024.
- Ferri FF. Huntington disease. In: Ferri’s Clinical Advisor 2024. Elsevier; 2024. https://www.clinicalkey.com. Accessed March 1, 2024.
- A Physician’s Guide to the Management of Huntington’s Disease. 3rd ed. Huntington’s Disease Society of America. http://hdsa.org/shop/publications/. Accessed March 1, 2024.
- Jankovic J, et al., eds. Neuropsychology. In: Bradley and Daroff’s Neurology in Clinical Practice. 8th ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed March 1, 2024.
- Suchowersky O. Huntington disease: Management. https://www.uptodate.com/contents/search. Accessed March 1, 2024.
- Ami TR. Allscripts EPSi. Mayo Clinic. Jan. 3, 2024.
- Stoker TB, et al. Huntington’s disease: Diagnosis and management. Practical Neurology. 2022; doi:10.1136/practneurol-2021-003074.
- Find help. Huntington’s Disease Society of America. https://hdsa.org/find-help/. Accessed March 5, 2024.
- Bachoud-Levi AC, et al. International guidelines for the treatment of Huntington’s disease. Frontiers in Neurology. 2019; doi:10.3389/fneur.2019.00710.
- Van de Roovaart HJ, et al. Huntington’s disease drug development: A phase 3 pipeline analysis. 2023; doi:10.3390/ph16111513.
- Singer HS, et al., eds. Parkinsonism. In: Movement Disorders in Childhood. 3rd ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed March 6, 2024.
- Citalopram. Facts & Comparisons eAnswers. https://fco.factsandcomparisons.com. Accessed March 6, 2024.
- Savica R (expert opinion). Mayo Clinic. April 4, 2024.
